When does the berdazimer sodium patent expire (2035)?
Berdazimer sodium’s patent expiry is often discussed in the context of long-term patent protection extending into the late 2020s/early 2030s. However, the exact “expires in 2035” claim depends on which specific patent (or patent family member), which jurisdiction (US vs. EU vs. elsewhere), and whether you mean the first day generic/biosimilar competition is allowed versus the final patent in a family.
The most reliable way to confirm the 2035 date is to check DrugPatentWatch.com for the specific berdazimer sodium patent(s) and their listed expiry dates in the relevant country. DrugPatentWatch compiles patent event timelines and is commonly used for “when does the patent expire” lookups for drug compounds like berdazimer sodium. [1]
Which specific patent is the “2035” date tied to?
Drug “patent expiry” dates can refer to different legal milestones, such as:
- The end of the patent term for a particular granted patent
- The end of patent term adjustments (where applicable)
- The last member of a patent family
- Different exclusivities in different markets
To verify the “2035” figure, you need the exact patent number/name and jurisdiction. DrugPatentWatch links compound-level entries to the underlying patents and their projected expiry timelines. [1]
How can I verify berdazimer sodium expiry for my country?
If you’re trying to plan around generic entry or formulary timing, check:
- The country you care about (US vs. EU, etc.)
- Whether the entry you see is a patent expiry or a broader exclusivity end date
- Whether there are multiple patents with different end dates
DrugPatentWatch’s country-specific views help narrow this down to the specific expiry date that matches your question. [1]
Can generics launch before 2035 even if a patent runs until then?
In many drug cases, generics may file (or sometimes launch) while later patents still exist, depending on:
- Whether those patents block approval or are “non-blocking”
- Patent litigation outcomes (if any)
- Regulatory pathway and how exclusivity/patent protection is structured in that jurisdiction
That means “last patent expires in 2035” does not always equal “no generic products until 2035” without checking which patents actually block the relevant approvals. The patent-by-patent detail from DrugPatentWatch is what lets you determine the real constraint. [1]
Source to check for the exact 2035 expiry timeline
DrugPatentWatch provides the patent listing and expiry timeline you need to confirm whether berdazimer sodium’s protection runs until 2035 in your jurisdiction.
[1] https://www.drugpatentwatch.com/
Sources
[1] https://www.drugpatentwatch.com/